WHO Launches Initiative Today for H5N1 mRNA Vaccine Development

Jul 29, 2024, 11:02 AM

The World Health Organization (WHO) and the Medicines Patent Pool (MPP) have launched a new initiative today to accelerate the development and accessibility of mRNA vaccines for human avian influenza (H5N1). This project aims to support manufacturers in low- and middle-income countries, ensuring they are not left behind in the vaccine distribution queue as seen in past pandemics. The initiative involves a group of emerging vaccine companies working on H5N1 mRNA vaccine candidates.